EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Double-edged mitophagy: balancing inflammation and resolution in lung disease

Sijia Tian iD, Yingyi Zhang iD, Chuanchuan Liu iD, Huajing Zhang, Qianying Lu iD, Yanmei Zhao iD, Haojun Fan iD

Clinical Science · 08.10.2025 · 139 (19) · 1047-1072

DOI: 10.1042/cs20256705 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Science, online erschienen am 30.09.2025. Verfasst von Sijia Tian und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Disaster and Emergency Medicine, Tianjin University, 300072, China. Hauptthemen laut MEDLINE: Mitophagy, Lung Diseases, Mitochondria, Inflammation. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory lung diseases, such as chronic obstructive pulmonary disease (COPD), acute lung injury (ALI)/acute respiratory distress syndrome (ARDS), and asthma, are driven by mitochondrial dysfunction and aberrant immune responses, yet the regulatory role of mitophagy—a selective autophagy eliminating damaged mitochondria—remains poorly defined. This review synthesizes evidence from in vivo and in vitro studies to dissect the molecular interplay between mitophagy and inflammation. Key fundings reveal that mitophagy exerts context-dependent effects: Protective mitophagy (via PTEN-induced putative kinase 1 [PINK1]-Parkin or FUN14 domain-containing protein 1 [FUNDC1] pathways) clears mitochondrial reactive oxygen species (mtROS)/mitochondrial DNA (mtDNA), suppressing NOD-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasome activation and pyroptosis, but excessive mitophagy exacerbates mitochondrial fragmentation and necroptosis. Notably, bidirectional cross-talk exists, and therapeutic strategies—genetic and pharmacological—could restore mitophagy flux, attenuating inflammation in preclinical models. However, challenges persist in targeting tissue-specific mitophagy (such as alveolar and bronchial epithelia). This work underscores mitophagy as a double-edged sword in lung inflammation and proposes precision interventions to balance mitochondrial quality control, offering novel avenues for inflammatory lung diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyLung DiseasesMitochondriaInflammationHumansAnimalsInflammasomes

Stichwörter der Autor:innen

inflammationlung diseasesmitophagymtROStherapeutic targeting

Substanzen

Inflammasomes

Autor:innen und Institutionen

  • School of Disaster and Emergency Medicine, Tianjin University, 300072, China.
  • Tianjin Key Laboratory of Disaster Medicine Technology, Tianjin, 300072, China.

ORCID-Profile: Sijia Tian, Yingyi Zhang, Chuanchuan Liu, Qianying Lu, Yanmei Zhao, Haojun Fan

Zitieren

APA

Tian, S., Zhang, Y., Liu, C., Zhang, H., Lu, Q., Zhao, Y., & Fan, H. (2025). Double-edged mitophagy: balancing inflammation and resolution in lung disease. Clinical Science, 139(19), 1047-1072. https://doi.org/10.1042/cs20256705

Vancouver

Tian S, Zhang Y, Liu C, Zhang H, Lu Q, Zhao Y, et al. Double-edged mitophagy: balancing inflammation and resolution in lung disease. Clinical Science. 2025;139(19):1047-1072. doi:10.1042/cs20256705

BibTeX
@article{Tian2025,
  author = {Tian, Sijia and Zhang, Yingyi and Liu, Chuanchuan and Zhang, Huajing and Lu, Qianying and Zhao, Yanmei and Fan, Haojun},
  title = {Double-edged mitophagy: balancing inflammation and resolution in lung disease},
  journal = {Clinical Science},
  year = {2025},
  volume = {139},
  number = {19},
  pages = {1047--1072},
  doi = {10.1042/cs20256705}
}
Kostenlos starten →